摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(6,7-dihydrobenzo[b]thiophen-4(5H)-ylidene)acetic acid | 102154-32-5

中文名称
——
中文别名
——
英文名称
2-(6,7-dihydrobenzo[b]thiophen-4(5H)-ylidene)acetic acid
英文别名
4-Carboxymethylidene-4,5,6,7-tetrahydrobenzo[b]thiophene;2-(6,7-dihydro-5H-1-benzothiophen-4-ylidene)acetic acid
2-(6,7-dihydrobenzo[b]thiophen-4(5H)-ylidene)acetic acid化学式
CAS
102154-32-5
化学式
C10H10O2S
mdl
——
分子量
194.254
InChiKey
AXQOKFDELGKCPU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    65.5
  • 氢给体数:
    1
  • 氢受体数:
    3

反应信息

  • 作为反应物:
    参考文献:
    名称:
    4,5,6,7-Tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
    摘要:
    本发明涉及对sigma (σ)受体具有药理活性的化合物,更具体地涉及一些4,5,6,7-四氢苯并[b]噻吩衍生物,其中n选择为0、1、2、3或4;m选择为0、1或2;虚线---代表单键或双键;本发明还涉及制备这种化合物的方法、包含它们的制药组合物以及它们在治疗和预防中的应用,特别是用于治疗精神病。
    公开号:
    EP1829869A1
点击查看最新优质反应信息

文献信息

  • 4,5,6,7-TETRAHYDROBENZO[B]THIOPHENE DERIVATIVES AND THEIR USE AS SIGMA RECEPTOR LIGANDS
    申请人:Corbera-Arjona Jordi
    公开号:US20090221572A1
    公开(公告)日:2009-09-03
    The present invention relates to compounds having pharmacological activity towards the sigma (σ) receptor, and more particularly to some 4, 5, 6, 7 tetrahydrobenzo[b]thiophene derivatives, wherein n is selected from 0, 1, 2, 3 or 4; m is selected from 0, 1 or 2; the dotted line represents either a single or a double bond; to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy and prophylaxis, in particular for the treatment of psychosis.
    本发明涉及具有对σ受体具有药理活性的化合物,更具体地涉及一些4,5,6,7-四氢苯并[b]噻吩衍生物,其中n从0,1,2,3或4中选择;m从0,1或2中选择;虚线表示单键或双键;涉及制备这些化合物的过程,包括它们的药物组成物,以及它们在治疗和预防中的使用,特别是用于治疗精神病。
  • Amidino substituted tetrahydrobenzo thiophene or furan derivatives and their use as urokinase inhibitors
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US06274619B1
    公开(公告)日:2001-08-14
    A compound of the formula: in which R1 is hydrogen, optionally substituted lower alkylcarbamoyl(lower)alkylidene, lower alkylidene, lower alkyl, optionally substituted ar(lower)alkyl, cyclo(lower)alkyl(lower)alkyl, protected carboxy(lower)alkyl, carboxy(lower)alkyl, hydroxy(lower)alkyl, optionally substituted lower alkylcarbamoyl(lower)alkyl, lower alkylthio(lower)alkyl, carboxy(lower)alkanoyl, protected carboxy(lower)alkanoyl, aroyl, lower alkanoyl, or optionally substituted arylcarbamoyl(lower)alkyl, R2 is hydrogen, carboxy, protected carboxy, formyl or N-(lower)alkyl-N-(lower)alkoxycarbamoyl, R3 is hydrogen or amidino-protective group, A is lower alkylene or carbonyl, X is Y is lower alkylene, —S— or —SO2—, Z is —S— or —O—, and the line: is a single bond or a double bond, or pharmaceutically acceptable salts thereof, which is useful as a medicament.
    一种化合物的化学式:其中,R1是氢,可选择性地取代下游戊二酰胺基(下)烷基亚烷基,下游烷基亚烷基,下游烷基,可选择性地取代芳基(下)烷基,环(下)烷基(下)烷基,保护羧基(下)烷基,羧基(下)烷基,羟基(下)烷基,可选择性地取代下游脲基(下)烷基,下游硫代(下)烷基,羧基(下)烷酰基,保护羧基(下)烷酰基,芳酰基,下游烷酰基,或可选择性地取代芳基脲基(下)烷基,R2是氢,羧基,保护羧基,甲酰基或N-(下)烷基-N-(下)烷氧基羰基,R3是氢或氨基保护基,A是下游亚烷基或羰基,X是Y是下游亚烷基,-S-或-SO2-,Z是-S-或-O-,线:是单键或双键,或其药学上可接受的盐,用作药物。
  • Benzothiophene derivatives, their preparation and use as urokinase
    申请人:Fujisawa Pharmaceutical Co., Ltd.
    公开号:US06093710A1
    公开(公告)日:2000-07-25
    A compound of the formula ##STR1## in which R.sup.1 is hydrogen, lower alkyl, optionally substituted ar(lower)alkyl, cyclo(lower)alkyl(lower)alkyl, protected carboxy)lower)alkyl, carboxy)lower)alkyl, hydroxy(lower)alkyl, optionally substituted lower alkylcarbamoyl(lower)alkyl, lower alkylthio(lower)alkyl, carboxy(lower)alkanoyl, protected carboxy(lower)alkanoyl, aroyl, lower alkanoyl, or optionally substituted arylcarbamoyl(lower)alkyl, R.sup.2 is hydrogen, carboxy, protected carboxy, formyl or N-(lower)alkyl-N-(lower)alkoxycarbamoyl, R.sup.3 is hydrogen or amidino-protective group, A is lower alkylene or carbonyl, X is ##STR2## Y is --S-- or --SO.sub.2 --, Z is --S-- or --O--, or pharmaceutically acceptable salts thereof which is useful as a medicament.
    该化合物的化学式为##STR1##其中R.sup.1是氢、低烷基、可选择取代的芳基(低)烷基、环(低)烷基(低)烷基、保护羧基(低)烷基、羧基(低)烷基、羟基(低)烷基、可选择取代的低烷基氨甲酰(低)烷基、低烷基硫(低)烷基、羧基(低)烷酰、保护羧基(低)烷酰、芳酰基、低烷酰基或可选择取代的芳基氨甲酰(低)烷基,R.sup.2是氢、羧基、保护羧基、甲酰或N-(低)烷基-N-(低)烷氧基甲酰基,R.sup.3是氢或酰胺基保护基,A是低烷基或羰基,X是##STR2## Y是--S--或--SO.sub.2 --,Z是--S--或--O--,或其药学上可接受的盐,可用作药物。
  • 4,5,6,7-tetrahydrobenzo[b]thiophene derivatives and their use as sigma receptor ligands
    申请人:Laboratorios del Dr. Esteve, S.A.
    公开号:US08227625B2
    公开(公告)日:2012-07-24
    The present invention relates to compounds having pharmacological activity towards the sigma (σ) receptor, and more particularly to some 4,5,6,7 tetrahydrobenzo[b]thiophene derivatives, wherein n is selected from 0, 1, 2, 3 or 4; m is selected from 0, 1 or 2; the dotted line represents either a single or a double bond; to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy and prophylaxis, in particular for the treatment of psychosis.
    本发明涉及具有对sigma (σ)受体具有药理活性的化合物,更具体地涉及一些4,5,6,7-四氢苯并[b]噻吩衍生物,其中n选择从0、1、2、3或4中选择;m选择从0、1或2中选择;虚线表示单键或双键;制备这种化合物的方法,包括它们的制药组合物,以及它们在治疗和预防中的用途,特别是用于治疗精神病。
  • 4,5,6,7-tetrahydrobenzo[B]thiophene derivatives and their use as sigma receptor ligands
    申请人:Corbera-Arjona Jordi
    公开号:US08492563B2
    公开(公告)日:2013-07-23
    The present invention relates to compounds having pharmacological activity towards the sigma (σ) receptor, and more particularly to some 4, 5, 6, 7 tetrahydrobenzo[b]thiophene derivatives, wherein n is selected from 0, 1, 2, 3 or 4; m is selected from 0, 1 or 2; the dotted line represents either a single or a double bond; to processes of preparation of such compounds, to pharmaceutical compositions comprising them, and to their use in therapy and prophylaxis, in particular for the treatment of psychosis.
    本发明涉及对σ受体具有药理活性的化合物,更具体地涉及一些4、5、6、7-四氢苯并[b]噻吩衍生物,其中n从0、1、2、3或4中选择;m从0、1或2中选择;虚线表示单键或双键;涉及制备这些化合物的方法,包括它们的制药组合物以及它们在治疗和预防中的使用,特别是用于治疗精神病。
查看更多

同类化合物

香薷二醇 顺式-1-(2-呋喃基)-1-戊烯 顺-1,2-二氰基-1,2-双(2,4,5-三甲基-3-噻吩基)乙烯 顺-1,2-(2-噻嗯基)二乙烯 雷尼替丁-N,S-二氧化物 雷尼替丁-N-氧化物 西拉诺德 螺[环氧乙烷-2,3'-吡咯并[1,2-a]吡嗪] 萘并[2,1,8-def]喹啉 苯硫基溴化镁 苯甲酸,2-[[[7-[[(3.β.)-3-羟基-28-羰基羽扇-20(29)-烯-28-基]amino]庚基]氨基]羰基] 苍术素 缩水甘油糠醚 紫苏烯 糠醛肟 糠醇-d2 糠醇 糠基硫醇-d2 糠基硫醇 糠基甲基硫醚 糠基氯 糠基氨基甲酸异丙酯 糠基丙基醚 糠基丙基二硫醚 糠基3-巯基-2-甲基丙酸酯 糠基-异戊基醚 糠基-异丁基醚 糠基 2-甲基-3-呋喃基二硫醚 磷杂茂 硫酸异丙基糠酯 硫代磷酸O-糠基O-甲基S-(2-丙炔基)酯 硫代磷酸O-乙基O-糠基S-(2-丙炔基)酯 硫代甲酸S-糠酯 硫代噻吩甲酰基三氟丙酮 硫代乙酸糠酯 硫代丙酸糠酯 硅烷,三(1-甲基乙基)[(3-甲基-2-呋喃基)氧代]- 硅烷,(1,1-二甲基乙基)(2-呋喃基甲氧基)二甲基- 砷杂苯 甲酸糠酯 甲氧亚胺基呋喃乙酸铵盐 甲基糠基醚 甲基糠基二硫 甲基呋喃-2-基甲基氨基甲酸酯 甲基丙烯酸糠酯 甲基5-(羟基甲基)-2-呋喃甲亚氨酸酯 甲基(2Z)-3-甲基-2-(甲基亚胺)-4-氧代-3,4-二氢-2H-1,3-噻嗪-6-羧酸酯 甲基(2Z)-3-氨基-2-(甲基亚胺)-4-氧代-3,4-二氢-2H-1,3-噻嗪-6-羧酸酯 甲基(2Z)-3-异丙基-2-(异丙基亚胺)-4-氧代-3,4-二氢-2H-1,3-噻嗪-6-羧酸酯 甲基(2-甲基-3-呋喃基)二硫